Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 13/20 | 0.70 |
| ▸ | MAOA | P21397 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | VCP | P55072 | 2/20 | 0.45 |
| ▸ | EGFR | P00533 | 2/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
| ▸ | ABL2 | P42684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6811553 | 0.84 | FBP1 (0.56) | FBP1MAOAMAOBVCPEGFR | |
| SCHEMBL6811555 | 0.84 | FBP1 (0.56) | FBP1MAOAMAOBVCPEGFR | |
| SCHEMBL30592090 | 0.82 | FBP1 (1.00) | FBP1MAOAMAOBVCP | |
| SCHEMBL3862500 | 0.82 | FBP1 (1.00) | FBP1MAOAMAOBVCP | |
| SCHEMBL3862508 | 0.82 | FBP1 (1.00) | FBP1MAOAMAOBVCP | |
| SCHEMBL794128 | 0.81 | FBP1 (1.00) | FBP1MAOAMAOBVCPEGFR | |
| SCHEMBL794129 | 0.81 | FBP1 (1.00) | FBP1MAOAMAOBVCPEGFR | |
| SCHEMBL21064478 | 0.75 | PTGS2 (0.58) | FBP1 | |
| SCHEMBL2285894 | 0.74 | FBP1 (0.67) | FBP1VCPEGFRABL1ABL2 | |
| SCHEMBL2285892 | 0.74 | FBP1 (0.67) | FBP1VCPEGFRABL1ABL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113660932-B | Phenyl derivatives having pendant alkyl and alkenyl extensions and pharmaceutical compositions comprising the same | 景凯生物科技股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20220153687-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | TAIWANJ PHARMACEUTICALS CO., LTD. (TW) | 2022-05-19 | — | — | US | disclosed |
| EP-3946299-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | Taiwanj Pharmaceuticals Co., Ltd. (TW) | 2022-02-09 | — | — | EP | disclosed |
| WO-2020205455-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | TAIWANJ PHARMACEUTICALS, CO., LTD. (TW) | 2020-10-08 | — | — | WO | disclosed |
| EP-2135858-A1 | COMPOSITION FOR TEATING INFECTIOUS DISEASES | Universidad De Zaragoza (ES) | 2009-12-23 | — | — | EP | disclosed |
| WO-1988003147-A1 | SELECTED N6-SUBSTITUTED ADENOSINES HAVING SELECTIVE A2 BINDING ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1988-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153687-A1 | PERIPHERAL ALKYL AND ALKENYL CHAINS EXTENDED BENZENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | AADAC, ENPP2, ATXN10 | FBP1 431/4885MAOA 191/4885MAOB 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.